Here, we report that inhibiting the mTOR pathway suppressed the growth of CD133-expressing (CD133+) pancreatic cancer cells and reduced pancreatic cancer cell sphere formation under stem cell culture conditions and colony formation in soft agar. This evidence concerns the gene PROM1 and familial pancreatic carcinoma.